PVI
CRVS icon

Pura Vida Investments’s Corvus Pharmaceuticals CRVS Stock Holding History

Pura Vida Investments’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-495,484
Closed -$813K – 226
2022
Q1 		$813K Buy
495,484
+3,100
+0.6% +$5.67K 0.03% 190
2021
Q4 		$1.19M Sell
492,384
-241,884
-33% -$938K 0.04% 168
2021
Q3 		$3.55M Buy
+734,268
New +$2.17M 0.11% 167

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Pura Vida Investments's CRVS Position: Q2 2022 in Review

Pura Vida Investments sold out of Corvus Pharmaceuticals (CRVS) in Q2 2022, closing a stake of 495,484 shares — an estimated $813K sold.

Pura Vida Investments first reported a position in CRVS in Q3 2021 and held it in 3 quarters. The position peaked at $3.55M in Q3 2021. 47 funds tracked by Wall St. Rank hold CRVS as of Q2 2022.

  • Pura Vida Investments reported no remaining Corvus Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 495,484 Corvus Pharmaceuticals shares in Q2 2022, an estimated $813K.
  • Pura Vida Investments first reported a position in Corvus Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Pura Vida Investments's Corvus Pharmaceuticals position peaked at $3.55M in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.